Mylan Laboratories Limited has received a risk category 1 ranking from the WHO Expert Review Panel for its generic injectable, medroxyprogesterone acetate depot 150mg/ml.
The first generic two-rod sub-dermal levonorgestrel 75mg implant product has received a positive result from the Expert Review Panel (ERP), making it the first of its kind to reach the quality standard for international procurement.
The WHO PQ team has announced the prequalification of a second mifepristone product, manufactured by Exelgyn in France.
Women Deliver will be holding their 2016 Conference in Copenhagen, Denmark, from 16-19 May 2016. Hope to see you there!
The WHO PQ Programme have announced the prequalification of an new levonorgestrel emergency contraceptive.